2 completed, 1 not yet recruiting. .
Follow Colitis, Ulcerative (UC): new trials by email Literature Review of Colitis, Ulcerative (UC) trials Research Report on Colitis, Ulcerative (UC)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Validation and Clinical Impact of GLIM Criteria in Patients With Inflammatory Bowel Disease Inflammatory Bowel Diseases, Crohn Disease | Not yet recruiting | Assiut University | 210 | 2026-11-01 | 2026-10-22 | |
| A Real-world Study of Imraldi® Use Adalimumab - Arthritis, Rheumatoid (RA), Axial Spondyloarthritis (axSpA) | Completed | Biogen | 1000 | 2019-06-30 | 2023-04-18 | |
| Chronic Inflammatory Disease, Lifestyle and Treatment Response Primary exposure variable, Other (exploratory) exposure variables - Autoimmune Diseases, Inflammatory Bowel Diseases | Completed | University of Southern Denmark | 233 | 2017-09-21 | 2021-07-02 |
Colitis, Ulcerative (3) · Crohn Disease (3) · Arthritis, Psoriatic (2) · Arthritis, Rheumatoid (2) · Inflammatory Bowel Diseases (2) · Autoimmune Diseases (1) · Axial Spondyloarthritis (1) · Hidradenitis Suppurativa (1) · Malnutrition (1) · Motor Activity (1) · Psoriasis (1) · Smoking (1) · Spondylarthropathies (1) · Uveitis (1)
Colitis (3) · Colonic Diseases (3) · Digestive System Diseases (3) · Gastroenteritis (3) · Gastrointestinal Diseases (3) · Intestinal Diseases (3) · Arthritis (2) · Bone Diseases (2) · Connective Tissue Diseases (2) · Immune System Diseases (2) · Joint Diseases (2) · Musculoskeletal Diseases (2) · Rheumatic Diseases (2) · Skin Diseases (2) · Skin Diseases, Papulosquamous (2)
Adalimumab (1) · Dietary Fiber (1)
Assiut University (1) · Biogen (1) · University of Southern Denmark (1)
Belgium (1) · Denmark (1) · Germany (1) · Ireland (1) · Italy (1) · Spain (1) · United Kingdom (1)
PMID 29439003, PMID 36313095, PMID 37632666, PMID 38973149, PMID 40545788